Methods: Stenotic or occlusive intracranial arterial lesions were collected from six autopsied patients who died of moyamoya disease. The cellular components were analyzed by immunohistochemical staining using cell-type-specific monoclonal antibodies. The sections were also immunostained for proliferating cell nuclear antigen (PCNA) to detect proliferating cells and for two different types of intermediate filaments, desmin and vimentin, to evaluate phenotypes of the intimal smooth muscle cells.
Results: The thickened intima was composed predominantly of smooth muscle cells with an admixture of some macrophages and T cells. Macrophages and T cells were scattered in the superficial layer of the intimal thickening, and these were occasionally associated with organization of fibrin thrombi. Proliferating smooth muscle cells, indicated by PCNA-positive nuclei and muscle actin-positive cytoplasm, were found in the thickened intima in four patients. Immunohistochemical 
Methods
Six autopsied patients with moyamoya disease, aged 14 to 66 years, were studied, and their clinical profiles are summarized in Table 1 . Diagnosis of moyamoya disease was established by angiographic findings, according to the previously described diagnostic criteria.4 5 At autopsy, the brains were removed and fixed in 10% formalin. After fixation, the arteries of the circle of Willis and their major branches at the base of the brain were removed and dehydrated through graded alcohol and chloroform series. The arterial specimens, including anterior, middle, and posterior cerebral arteries, intracranial portion of internal carotid arteries, and basilar artery, were then cut into segments approximately 3 mm long and embedded in paraffin. Sections, (Fig 2) . In two patients aged older than 50 years (patients 5 and 6), lipid-filled macrophages accumulated in the gruel of atheroma formed in the deep intima. cells were positively stained for both vimentin and desmin. In contrast, the intimal smooth muscle cells were positive for vimentin and negative for desmin, although these cells were positive for muscle actin and smooth muscle-specific a-actin (Fig 4) . A similar staining pattern was observed in all patients.
The six control subjects aged younger than 50 years showed no significant intimal thickening except for focal accumulation of smooth muscle cells at branching points (intimal cushion). The muscle cells were localized in the superficial layer of the intimal thickening, and macrophages were distributed in similar areas. The phenotypes of smooth muscle cells were shown to be modulated in the intima from contractile to synthetic, as suggested by loss of desmin expression. This phenotypic modulation has been described in neointima formed after endothelial denudation in experimental animals,12"3 in the fibrocellular response after percutaneous transluminal coronary angioplasty,'4 and in atherosclerotic plaques.15 It is therefore possible to speculate that common mechanisms leading to the migration and proliferation of smooth muscle cells may be involved.
The present report has first described the immunostaining for PCNA in human cerebral arteries. To our knowledge, there has been only one published report in which human arteries were immunostained for PCNA. 16 This report stated that there were very few PCNApositive cells in internal mammary arteries and coronary arteries (less than 1% of the cells), although the atherosclerotic plaque in coronary arteries showed a slightly higher PCNA index than the underlying media. Recently, Gelb et al17 analyzed some factors affecting the reactivity of the immunostaining for PCNA on formalin-fixed, paraffin-embedded tissues. They reported that PC1O, the monoclonal antibody used in our study, is a more reliable marker than another commercially available antibody, 19A2, and that the epitope of PCNA recognized by PC10 may be more resistant to alteration by formalin fixation.
In fact, the antibody PC10 immunostained the nuclei of the mucosal epithelium lining crypts of the small intestine in all cases; it also stained those of smooth muscle cells in the intimal thickenings observed in intracranial arteries in four of six patients. In the age-matched control subjects, smooth muscle proliferation was not detectable in the intima of the intracranial major arteries of the brain by PCNA immunostaining, and atherosclerotic changes became apparent after 50 years of age. The cerebral arteries are generally resistant to atherosclerotic change,'8 and thus it is not surprising that smooth muscle proliferation is undetectable by PCNA immunostaining in the control subjects. From these observations, it is reasonable to conclude that the appearance of PCNApositive smooth muscle cells in the stenotic intracranial arterial lesions in patients with moyamoya disease is not related to atherosclerotic changes and is pathognomonic for moyamoya disease. The variation of the stainability for PCNA is unable to be explained by how soon after the death the brains were fixed (Table 1) . It is speculated to be a reflection of the stage and/or activity of the pathological process, but definite conclusions should not be drawn because the factors affecting reactivity, such as postmortem changes, selection of the fixatives and the solvents for dehydration, and the fixation duration are not fully understood.
It has been suggested that hereditary factors play a role in the etiology of moyamoya disease, as indicated by the high incidence among the Japanese, occasional familial occurrence, and association with other anomalies; however, the etiology still remains unclear. 45'1920 Several studies have suggested that an acquired disorder, ie, chronic arteritis due to immunologic reactions, 23 In fact, accumulation of lipid-filled macrophages and T cells were found in the control subjects aged older than 50 years in the gruel of atheroma found in the deep intima. In those aged younger than 50 years, however, the cerebral arteries had only focal intimal cushions and no significant intimal thickening, and macrophages were rarely observed in the intima. Thus, it is speculated that infiltration of inflammatory cells observed in the patients aged younger than 50 years may be related to the pathological process of moyamoya disease, although the possibilities of a concomitant progression of atherosclerosis and/or other nonspecific changes unrelated to moyamoya disease are not completely excluded.
Proliferating smooth muscle cells revealed by positive staining for PCNA were localized within the superficial layer of the lesions, and macrophages and T cells were scattered in similar areas. These observations suggest that the inflammatory response may play a role in inducing proliferation of smooth muscle cells. The distribution of proliferating cells may explain the gradual progression of stenosis that has been observed in follow-up angiographic studies.45 Previous histopathologic studies have stressed the presence of intra-arterial microthrombi in the stenotic arteries and have suggested that their components, such as platelets and plasma constituents, may play a role in inducing the smooth muscle response.6,24 However, microthrombi were absent from most of the cases in the present study. The covering endothelium was not present for the most part, irrespective of the presence or absence of intimal thickenings in the pathological specimens. This loss is probably related not to endothelial damage or denudation in situ but to postmortem changes. However, we found macrophage and T cell infiltration not only in areas containing microthrombi but in those without microthrombi, indicating that the inflammatory reaction preceded microthrombus formation. Therefore, it is possible that microthrombus formation is secondary to the stenosis or to the preceding chronic inflammation. 
Editorial Comment
The primary lesion of moyamoya disease is stenosis or occlusion at or around the distal ends of both internal carotid arteries. This is thought to result in an extensive collateral circulation including a fine network of vessels at the base of the brain, termed "moyamoya," meaning "foggy" in Japanese.1-3 This disease is rare, although the patients have been much more frequently encountered in Japan than in other countries since the presumed first case was described in 1957. 4 The incidence is thought to be one per million people per year, and the Japanese nationwide total of patients identified up to the end of 1990 was estimated to be 3000.5 Therefore, it is remarkable that the authors of this report were able to collect six autopsied patients with moyamoya in such a short time.
Many Whether these pathological changes occur only in the stenotic intracranial arteries or also appear in extracranial and systemic arteries is another important issue.9 Previous reports have shown the possible role of growth factors such as platelet-derived growth factor'0 and basic fibroblast growth factor" on the development of collateral vessels in this disease. Further studies are necessary to clarify the stimuli that promote the chronic inflammatory response. This might lead to clues regarding whether
